Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man

Biochemical Pharmacology

Volumn 37, Issue 1, 1988, Pages 93-96

  Eichelbaum, M ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; DRUG METABOLISM; HUMAN; PRIORITY JOURNAL; STEREOSPECIFICITY;

HUMAN; MOLECULAR CONFORMATION; OXIDATION-REDUCTION; PHARMACOKINETICS; PHARMACOLOGY; STEREOISOMERISM;

EID: 0023864115     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(88)90758-7     Document Type: Article

References (20)

1. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
2. Physiological disposition of verapamil in man
3. Effects of verapamil on PR intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatment
4. The effect of dextro, levo and racemic verapamil on atrioventricular conduction in man
5. Pharmacokinetics of (+)-, (−)- and (±)-verapamil after intravenous administration
6. Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique
7. Effects of d,l-verapamil on atrioventricular conduction in relation to its Stereoselective first-pass metabolism
8. Metabolism of D, L, (C14) verapamil in man
9. Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis
10. 13C) warfarin pseudoracemates in man
11. The warfarin-sulfinpyrazone interaction: stereochemical considerations
12. Polymorphic drug oxidation in humans
13. The debrisoquine hydroxylation gene: A gene of multiple consequence
14. Pharmacogenetics of mephenytoin A new drug hydroxylation polymorphism in man
15. Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol
16. Steric configuration and polymorphic oxidation of lipophilic beta-adrenoceptor blocking agents: in vivo-in vitro correlations
17. Polymorphism of propafenone metabolism in man: clinical and pharmacokinetic consequences
18. Absolute configuration of 1234-tetrahydro-4-hydroxyisoquinolines
19. Stereochemische Aspekte der polymorphen 4-Hydroxylierung von Debrisoquin beim Menschen
20. The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation